Cover Image
市場調查報告書

骨癌:全球臨床實驗檢討

Bone Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 212841
出版日期 內容資訊 英文 183 Pages
訂單完成後即時交付
價格
Back to Top
骨癌:全球臨床實驗檢討 Bone Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月26日 內容資訊: 英文 183 Pages
簡介

本報告提供全球骨癌治療藥的臨床實驗資料,提供各國的趨勢,彙整臨床實驗數,潛力治療藥物,及主要企業和研究機關的臨床實驗狀況,為您概述為以下內容。

目錄

簡介

  • 骨癌
  • 報告指南

臨床實驗 各地區

  • 臨床實驗 各國
    • 對臨床實驗有所貢獻的前五國 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美
    • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
    • 對臨床實驗有所貢獻的前幾名國家 - 中南美

臨床實驗:G7 各國

臨床實驗:G7 各國 各臨床實驗狀態

臨床實驗:E7 各國

臨床實驗:E7 各國 各臨床實驗狀態

臨床實驗 各階段

  • 進行中的臨床實驗 各階段

臨床實驗 各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

主要的參與臨床實驗企業

潛力治療藥物

臨床實驗 簡介

  • 臨床實驗概要: 前幾名企業
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Bayer AG
    • 武田藥品工業
    • Merck & Co., Inc.
    • Pfizer Inc.
    • AstraZeneca PLC
    • Eli Lilly and Company
    • Algeta ASA
  • 臨床實驗概要: 最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • Children's Oncology Group
    • The University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • Massachusetts General Hospital
    • European Organization for Research and Treatment of Cancer
    • Southwest Oncology Group
    • University Health Network
    • Stanford University

5個主要的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC1995CTIDB

GlobalData's clinical trial report, "Bone Cancer Global Clinical Trials Review, H1, 2014" provides data on the Bone Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bone Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Bone Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bone Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Bone Cancer
    • Jan 03, 2014: Eleison Announces Achievement of Enrollment Milestone in its Phase II Trial of ILC for Pediatric Bone Cancer
    • Oct 22, 2012: Eleison Enrolls First Patient In Phase II Trial Of Cisplatin For Pediatric Bone Cancer
    • Aug 07, 2012: Philips And Celsion Announce FDA Clearance To Commence Phase II Study Of ThermoDox And MR-Guided HIFU In Bone Cancer
    • Mar 02, 2012: Niiki Pharma To Begin Phase I Trial Of NKP-2235
    • Nov 14, 2011: Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy In Bone Cancer Model
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Algeta ASA
      • Clinical Trial Overview of Algeta ASA
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Southwest Oncology Group
      • Clinical Trial Overview of Southwest Oncology Group
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bone Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Bone Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bone Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Bone Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Bone Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Algeta ASA, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014*
  • Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*

List of Figures

  • Bone Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Bone Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top